Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors

被引:32
|
作者
Shaikh, Abdul Rajjak
Ismael, Mohamed
Del Carpio, Carlos A. [1 ]
Tsuboi, Hideyuki
Koyama, Michihisa
Endou, Akira
Kubo, Momoji
Broclawik, Ewa
Miyamoto, Akira
机构
[1] Tohoku Univ, Grad Sch Engn, Dept Appl Chem, Aoba Ku, Sendai, Miyagi 9808579, Japan
[2] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan
[3] Polish Acad Sci, Inst Catalysis, PL-30239 Krakow, Poland
[4] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan
关键词
3D-QSAR; MFA; RSA; c-Jun N-terminal kinase-3; JNK3; inhibitors; docking;
D O I
10.1016/j.bmcl.2006.06.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for 44 (benzothiazole2-yl) acetonitrile derivatives, inhibiting c-Jun N-terminal kinase-3 (JNK3). It includes molecular field analysis (MFA) and receptor surface analysis (RSA). The QSAR model was developed using 34 compounds and its predictive ability was assessed using a test set of 10 compounds. The predictive 3D-QSAR models have conventional r(2) values of 0.849 and 0.766 for NIFA and RSA, respectively; while the cross-validated coefficient r(2) values of 0.616 and 0.605 for NIFA and RSA, respectively. The results of the QSAR model were further compared with a structure-based analysis using docking studies with crystal structure of JNK3. Ligands bind in the ATP pocket and the hydrogen bond with GLN155 was found to be crucial for selectivity among other kinases. The results of 3D-QSAR and docking studies validate each other and hence, the combination of both methodologies provides a powerful toot directed to the design of novel and selective JNK3 inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5917 / 5925
页数:9
相关论文
共 50 条
  • [1] Insights into the c-Jun N-terminal kinase 3 (JNK3) inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
    Yanda Liu
    Yewei Xie
    Yuanyuan Liu
    Pengcheng Wang
    Jiaxi Ye
    Yalun Su
    Zhihong Liang
    Zhaohui He
    Haibo Zhou
    Guochao Liao
    Jun Xu
    Yiqun Chang
    Pinghua Sun
    Medicinal Chemistry Research, 2019, 28 : 1796 - 1805
  • [2] Insights into the c-Jun N-terminal kinase 3 (JNK3) inhibitors: CoMFA, CoMSIA analyses and molecular docking studies
    Liu, Yanda
    Xie, Yewei
    Liu, Yuanyuan
    Wang, Pengcheng
    Ye, Jiaxi
    Su, Yalun
    Liang, Zhihong
    He, Zhaohui
    Zhou, Haibo
    Liao, Guochao
    Xu, Jun
    Chang, Yiqun
    Sun, Pinghua
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (10) : 1796 - 1805
  • [3] Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology
    Ijjaali, Ismail
    Petitet, Francois
    Dubus, Elodie
    Barberan, Olivier
    Michel, Andre
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (12) : 4256 - 4264
  • [4] Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses
    Sharma, Pooja
    Ghoshal, Nanda
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (04) : 1763 - 1774
  • [5] 3D-QSAR and docking studies of aminopyridine carboxamide inhibitors of c-Jun N-terminal kinase-1
    Yi, Ping
    Qiu, Minghua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (03) : 604 - 613
  • [6] Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase
    De, Surya K.
    Barile, Elisa
    Chen, Vida
    Stebbins, John L.
    Cellitti, Jason F.
    Machleidt, Thomas
    Carlson, Coby B.
    Yang, Li
    Dahl, Russell
    Pellecchia, Maurizio
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (08) : 2582 - 2588
  • [7] Novel Tryptanthrin Derivatives with Selectivity as c-Jun N-Terminal Kinase (JNK) 3 Inhibitors
    Schepetkin, Igor A.
    Karpenko, Oleksander S.
    Kovrizhina, Anastasia R.
    Kirpotina, Liliya N.
    Khlebnikov, Andrei I.
    Chekal, Stepan I.
    Radudik, Alevtyna V.
    Shybinska, Maryna O.
    Quinn, Mark T.
    MOLECULES, 2023, 28 (12):
  • [8] Novel diaminopyrimidine inhibitors of c-Jun N-terminal kinase 3 (JNK3): SAR and ligand co-crystallization studies.
    Ma, V
    Tempest, PA
    Pettus, L
    Jona, J
    Henley, C
    Surapaneni, S
    Magal, E
    Powers, D
    Xie, YY
    Mohr, C
    Sun, Y
    Jordan, S
    Harte, B
    Hungate, R
    Hulme, C
    Meyer, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U197 - U197
  • [9] Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38
    Kamenecka, Ted
    Habel, Jeff
    Duckett, Derek
    Chen, Weimin
    Ling, Yuan Yuan
    Frackowiak, Bozena
    Jiang, Rong
    Shin, Youseung
    Song, Xinyi
    LoGrasso, Philip
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (19) : 12853 - 12861
  • [10] In Silico Design of Novel Tetra-Substituted Pyridinylimidazoles Derivatives as c-Jun N-Terminal Kinase-3 Inhibitors, Using 2D/3D-QSAR Studies, Molecular Docking and ADMET Prediction
    Abdellah El Aissouq
    Hamid Toufik
    Mourad Stitou
    Abdelkrim Ouammou
    Fatima Lamchouri
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 1335 - 1351